Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Werewolf Therapeutics Inc (HOWL)

Werewolf Therapeutics Inc (HOWL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 47,566
  • Shares Outstanding, K 44,874
  • Annual Sales, $ 1,890 K
  • Annual Income, $ -70,520 K
  • EBIT $ -74 M
  • EBITDA $ -73 M
  • 60-Month Beta 0.62
  • Price/Sales 25.00
  • Price/Cash Flow N/A
  • Price/Book 0.82

Options Overview Details

View History
  • Implied Volatility 758.68% ( +495.76%)
  • Historical Volatility 93.50%
  • IV Percentile 96%
  • IV Rank 67.35%
  • IV High 1,118.91% on 04/10/25
  • IV Low 15.47% on 10/15/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 62
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 1,642
  • Open Int (30-Day) 1,669

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.50
  • Number of Estimates 5
  • High Estimate -0.39
  • Low Estimate -0.84
  • Prior Year -0.43
  • Growth Rate Est. (year over year) -16.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0150 +10.34%
on 06/30/25
1.4700 -23.81%
on 06/10/25
-0.2900 (-20.57%)
since 06/09/25
3-Month
0.6402 +74.95%
on 04/11/25
1.5100 -25.83%
on 06/09/25
+0.4003 (+55.62%)
since 04/09/25
52-Week
0.5950 +88.24%
on 04/07/25
4.1800 -73.21%
on 10/23/24
-1.2200 (-52.14%)
since 07/09/24

Most Recent Stories

More News
Werewolf Therapeutics to Participate in the KidneyCAN 7th Annual Kidney Cancer Research Summit

HOWL : 1.1200 (+5.66%)
Werewolf Therapeutics to Participate in the BIO International Convention

HOWL : 1.1200 (+5.66%)
Werewolf Therapeutics to Participate in the Upcoming Jefferies Global Healthcare Conference

HOWL : 1.1200 (+5.66%)
HonorHealth Research Institute patient with advanced skin cancer in remission for more than a year following clinical trial of Werewolf Therapeutics' investigational novel conditionally activated IL-2 pro-drug WTX-124

HOWL : 1.1200 (+5.66%)
Werewolf Therapeutics to Participate in Hanson Wade’s 6th Annual Cytokine-Based Drug Development Summit

HOWL : 1.1200 (+5.66%)
Werewolf Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

HOWL : 1.1200 (+5.66%)
Werewolf Therapeutics Presents New Preclinical Data Further Characterizing its IL-10 INDUKINE Molecule, WTX-921, for the Treatment of Inflammatory Bowel Disease (IBD) at AAI Annual Meeting

HOWL : 1.1200 (+5.66%)
Werewolf Therapeutics to Participate in Upcoming Investor Conferences

HOWL : 1.1200 (+5.66%)
Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer

HOWL : 1.1200 (+5.66%)
Werewolf Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

HOWL : 1.1200 (+5.66%)

Business Summary

Werewolf Therapeutics Inc. is a biopharmaceutical company. It involved in the development of conditionally activated therapeutics engineered to stimulate the body's immune system for the treatment of cancer. Werewolf Therapeutics Inc. is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 1.1067
2nd Resistance Point 1.0933
1st Resistance Point 1.0767
Last Price 1.1200
1st Support Level 1.0467
2nd Support Level 1.0333
3rd Support Level 1.0167

See More

52-Week High 4.1800
Fibonacci 61.8% 2.8105
Fibonacci 50% 2.3875
Fibonacci 38.2% 1.9645
Last Price 1.1200
52-Week Low 0.5950

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar